Zoetis
ZTS
$0.83 (-0.49%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
CNBC Television • 4 days ago • ZTS
Zoetis CEO Kristin Peck sits down with Jim CramerPRNewsWire • 5 days ago • ZTS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTSSeeking Alpha • 6 days ago • ZTS
Zoetis: Why The Focus On Companion Animal Segment Will Pay OffBusiness Wire • 7 days ago • ZTS
Zoetis to Participate in the William Blair 44th Annual Growth Stock ConferenceCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.